UK markets close in 2 hours 46 minutes

AstraZeneca PLC (AZN.L)

LSE - LSE Delayed price. Currency in GBp (0.01 GBP)
Add to watchlist
12,210.00-50.00 (-0.41%)
As of 01:29PM BST. Market open.
Currency in GBp

Valuation measures4

Market cap (intra-day) 190.06B
Enterprise value 210.59B
Trailing P/E 39.11
Forward P/E 18.73
PEG ratio (5-yr expected) 0.98
Price/sales (ttm)5.20
Price/book (mrq)6.56
Enterprise value/revenue 5.72
Enterprise value/EBITDA 19.77

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 320.20%
S&P500 52-week change 324.16%
52-week high 312,704.00
52-week low 39,461.00
50-day moving average 312,284.28
200-day moving average 310,948.85

Share statistics

Avg vol (3-month) 32.08M
Avg vol (10-day) 31.2M
Shares outstanding 51.55B
Implied shares outstanding 61.55B
Float 81.54B
% held by insiders 10.04%
% held by institutions 149.91%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 42.28
Forward annual dividend yield 41.86%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 30.02%
5-year average dividend yield 42.41
Payout ratio 471.30%
Dividend date 3N/A
Ex-dividend date 422 Feb 2024
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.30%
Operating margin (ttm)26.11%

Management effectiveness

Return on assets (ttm)7.04%
Return on equity (ttm)17.29%

Income statement

Revenue (ttm)47.61B
Revenue per share (ttm)30.74
Quarterly revenue growth (yoy)16.50%
Gross profit (ttm)N/A
EBITDA 15.8B
Net income avi to common (ttm)6.33B
Diluted EPS (ttm)3.14
Quarterly earnings growth (yoy)20.90%

Balance sheet

Total cash (mrq)8.02B
Total cash per share (mrq)5.18
Total debt (mrq)34.69B
Total debt/equity (mrq)92.51%
Current ratio (mrq)0.89
Book value per share (mrq)24.17

Cash flow statement

Operating cash flow (ttm)9.7B
Levered free cash flow (ttm)8.68B